Home · Health · Oct 5 archive
Financial Incentives Boost Smoking Cessation in Lung Cancer Screening
Developing
In Short: A study published in Medscape reveals that financial incentives significantly enhance smoking cessation rates among individuals referred for lung cancer screening (LCS).
The research found that financial incentives contingent on biochemically confirmed smoking cessation more than doubled the sustained tobacco abstinence rates through six months compared to standard care.
Specifically, the study compared different approaches: ask-advise-refer alone, which achieved a 4.3% abstinence rate; ask-advise-refer plus free pharmacotherapy, achieving a 5.1% rate; and ask-advise-refer plus financial incentives, which saw an 8.8% abstinence rate.
The highest abstinence rate, 8.8%, was observed when financial incentives (up to $600) were combined with a mobile health tool, though this combination did not surpass the rate achieved with financial incentives alone.
The authors emphasize that smoking cessation enhances the effectiveness of LCS, further reducing mortality and morbidity, with estimates indicating that achieving abstinence in 10% to 15% of screened individuals prevents 70% to 80% more deaths.
What's still developing
- Nothing material beyond the confirmed record.
Sources
- Medscapelink